The advance helped the benchmarks cut all their losses in 2025, though analysts are guarded about concluding that the recovery is here to stay. The outcome of the Reserve Bank of India’s monetary policy meeting on Friday will be the next trigger for the market.
Sun Pharma deal structurally strong, debt the only overhang: Amit Khurana
Market expert Amit Khurana offers insights on key corporate and regulatory developments. Sun Pharma’s acquisition is seen as strategically sound, though debt requires careful management.